Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells

Blood

Volumn 102, Issue 9, 2003, Pages 3147-3153

  Li, Ke ^b   Menon, Madhu P ^b   Karur, Vinit G ^b   Hegde, Shaflaja ^b   Wojchowski, Don M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; ERYTHROPOIETIN RECEPTOR HM; GROWTH FACTOR; INTERLEUKIN 3; JANUS KINASE; JANUS KINASE 2; PHENYLHYDRAZINE; PHOSPHOTYROSINE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BINDING SITE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT E; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ANALYSIS; ERYTHROID G1E2 CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; IN VIVO STUDY; KNOCKIN MOUSE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN FUNCTION; STRAIN DIFFERENCE; WILD TYPE;

EID: 0142245612     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0078     Document Type: Article

References (55)

1. Ihle JN. Cytokine receptor Signaling. Nature. 1995;377:591-594.
2. Bagley CJ, Woodcock JM, Guthridge MA, Stomski FC, Lopez AF. Structural and functional hot spots in cytokine receptors. Int J Hematol. 2001;73:299-307.
3. Barbone FP, Middleton SA, Johnson DL, et al. Mutagenesis studies of the human erythropoietin receptor: establishment of structure-function relationships. J Biol Chem. 1997;272:4985-4992.
4. De Vos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992;255:306-312.
5. Gadina M, Hilton D, Johnston, et al. Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol. 2001;13:363-373.
6. Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS. The conserved box 1 motif of cytokine receptors is required for association with JAK kinase. J Biol Chem. 1995;270:6523-6530.
7. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002;109:S121-S131.
8. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285:1-24.
9. Pawson T, Raina M, Nash P. Interaction domains: from simple binding events to complex celluar behavior. FEBS Lett. 2002;513:2-10.
10. Hibi M, Hirano T. Signal transduction through cytokine receptors. Int Rev Immunol. 1998;17:75-102
11. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood. 1994;84:1501-1507.
12. Jiang N, He TC, Miyajima A, Wojchowski DM. The box 1 domain of the erythropoietin receptor specifies Jak2 activation and functions mitogenically within an interleukin 2 receptor chimera. J Biol Chem. 1996;271:16472-16476.
13. Krishnan K, Pine R, Krolewski JJ. Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner. Eur J Biochem. 1997;247:298-305.
14. Zhuang H, Niu Z, He TC, Patel SV, Wojchowski DM. Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J Biol Chem. 1995;270:14500-14504.
15. Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998;93:397-409.
16. Nosaka T, van Deursen JM, Tripp RA, et al. Defective lymphoid development in mice lacking Jak3. Science. 1995;270:800-802.
17. Decker T, Stockinger S, Karaghiosoff M, Muller M, Kovarik P. IFNs and STATs in innate immunity to microorganisms. J Clin Invest. 2002;109:1271-1277.
18. Farrar MA, Campbell JD, Schrelber RD. Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor. Proc Natl Acad Sci U S A. 1992;89:11706-11710.
19. McLemore ML, Grewai S, Liu F, et al. Stat3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 2001;14:193-204.
20. Ward AC, Hermans MH, Smith L, et al. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood. 1999;93:113-124.
21. Gaur M, Murphy GJ, deSauvage FJ, Leavitt AD. Characterization of Mpl mutants using primary megakarocyte-lineage cells from mpl(-/-): a new system for Mpl structure-function studies. Blood. 2001;97:1652-1661.
22. Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene. 2000;19:2585-2597.
23. Joneja B, Wojchowski DM. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box 1 domain. J Biol Chem. 1997;272:11176-11184.
24. Nakamura N, Chin H, Miyasaka N, Miura O. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells. J Biol Chem. 1996;271:19483-19488.
25. Zhao S, Zoller K, Masuko M, et al. Jak2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells. EMBO J. 2002;21:2159-2167.
26. Miller CP, Liu ZY, Noguchi CT, Wojchowski DM. A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development. Blood. 1999;94:3381-3387.
27. Miller CP, Heilman DW, Wojchowski DM. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms. Blood. 2002;99:898-904.
28. Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO J. 2001;20:3156-3166.
29. Geiger JN, Kundsen GT, Panek K, et al. mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development. Blood. 2001;97:901-910.
30. Zhang D, Johnson MM, Miller CP, Pircher TJ, Geiger JN, Wojchowski DM. An optimized system for studies of Epo-dependent murine pro-erythroblast development. Exp Hematol. 2001;29:1278-1288.
31. Panzenbock B, Partunek P, Mapara MY, Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood. 1998;92:3658-3668.
32. Weiss MJ, Yu C, Orkin SH. Erythroid cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of gene-target cell line. Mol Cell Biol. 1997;17:1642-1651.
33. Kina T, Ikuta K, Takayama E, et al. The monoclonal antibody Ter-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000;109:280-287.
34. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990;248:378-381.
35. -/- mice due to decreased survival of early erythroblasts. Blood. 2001;98:3261-3273.
36. Kuypers FA. Phospholipid asymmetry in health and disease. Curr Opin Hematol. 1998;5:122-131.
37. Rinaudo D, Toniatti C. Sensitive ELISA for mouse erythropoietin. Biotechniques. 2000;29:218-220.
38. Tilbrook PA, Klinken SP. Erythropoietin and erythropoietin. Growth Factors. 1999;17:25-35.
39. L allows factor-independent differentiation of primary erythroblasts. Curr Biol. 2002;12:1076-1085.
40. Wagner KU, Claudio E, Rucker EB, et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development. 2000;127:4949-4958.
41. Quelle FW, Wang D, Nosaka T, et al. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Bioi. 1996;16:1622-1631.
42. Quelle FW, Wang J, Feng J, et al. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes Dev. 1998;12:1099-1107.
43. Gregory RC, Jiang N, Todokoro K, Crouse J, Pacifici RE, Wojchowski DM. Erythropoietin receptor and Stat5-specific pathways promote SKT6 cell hemoglobinization. Blood. 1998;92:1104-1118.
44. Miura O, Miura Y, Nakamura N, et al. Induction of tyrosine phophorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood. 1994;84:4135-4141.
45. Kubota Y, Tanaka T, Kitanaka A, et al. Src transduces erythropoietin-induced differentiation signals through phophatidylinositol 3-kinase. EMBO J. 2001;20:5666-5677.
46. Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O. Lyn physically associates with the erythropoietin receptor and may play a role in activation of Stat5 pathway. Blood. 1998;91:3734-3745.
47. Klingmuller U, Wu H, Hsiao JG, et al. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A. 1997;94:3016-3021.
48. Bouscary D, Pene F, Claessens YE, et al. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood. 2003;101:3436-3443.
49. Hortner M, Nielsch U, Mayr LM, Heinrich PC, Haan S. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Eur J Biochem. 2002;269:2516-2526.
50. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 1995;80:729-738.
51. Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. Two new Epo receptor mutations: truncated Epo receptors are most frequently associated with primary familial and congenital polycythemias. Blood. 1997;90:2057-2061.
52. Bozzini CE, Alippi RM, Barcelo AC. Enhanced effect of increased erythrocyte production rate on plasma erythropoietin levels of mice during subsequent exposure to hypobaria. Adv Exp Med Biol. 1989;271:23-27.
53. Bauer A, Tronche F, Wessely O, et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 1999;13:2996-3002.
54. Maguer-Satta V, Bartholin L, Jeanpierre S, et al. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family. Exp Cell Res. 2003;282:110-120.
55. von Lindern M, Deiner EM, Dolznig, et al. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. Oncogene. 2001;20:3651-3664.